Skip to content

To assess the effectiveness of an Ayurvedic formulation Gomutra Haritaki in improving iron deficiency status in anemia(Pandu Roga)

Clinical Study to evaluate the efficacy of Gomutra Haritaki for improving iron deficiency status in Pandu Roga

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031701
Enrollment
60
Registered
2021-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E638- Other specified nutritional deficiencies

Interventions

Intervention1: Gomutra Haritaki: 30 patients will be randomly selected for this group and they will be treated for 30 days with 5 gram of Haritaki churna with 10 ml goark diluted with 50 ml of luke wa

Sponsors

Chaudhary Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group 18 and 60 years Patients having any five or more amongst the cardinal symptoms of Pandu Roga i.e 1. Karnswead (tinitus) 2. Hatanal (suppression of the power of digestion) 3. Sadan (prostration) 4. Anndwesh (repugnance against food) 5. Daurbalyta (Weakness) 6. Shrama (fatigue) 7. Gatrashool (pain in body) 8. Jwara (fever) 9. Shwasa (exertional dyspnoea), 10. Gaurav (heaviness) 11. Aruchi (Loss of Appetite) 12. Shunakshikuta Shotha (Oedema around Eyes) 13. Harita (greenish complexion) 14. Shirnaloma (fall of small body hairs) 15. Hritprabha (loss of bodyâ??s lusture) 16. Kopana (becomes irritating) 17. Shishirdweshi (dislikes cold things) 18. Nidralu (excessive feeling of sleepiness) 19. Shthiwan (excessive spit) 20. Alpawak (avoid speaking) 21. Pindikodveshtana (cramp in calf muscle ), 22. Katiurupaadruksadan (while climbing suffer pain and weakness in lower limb,thigh,feet ) 23. Hridspandanam (Palpitation) 24. Bhrama (vertigo), Patients having Hb% less than 12 gm/dl and more than 8.00 gm/dl for females. Patients having Hb% less than 13 gm/dl and more than 8.00 gm/dl for males

Exclusion criteria

Exclusion criteria: Patients suffering from systemic diseases like renal disorders, heart disease, cancer, acquired immunedeficiency syndrome, tuberculosis., hypertension, and having bleeding disorders Any other type of anaemia except Iron Deficiency Anaemia. Age Hb% level-below 8 gm/dl Anaemia in a case of defective absorption due to gastrectomy, sprue syndrome etc. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Improvement in the findings of serum ferritin. Timepoint: DAY1 DAY45 DAY45

Secondary

MeasureTime frame
Clinical improvement in the clinical feature of Iron Deficiency Anemia. Improvement in haemoglobin concentration. Timepoint: DAY1 DAY30 DAY45

Countries

India

Contacts

Public ContactDr Arun Kumar

Ch Brahm Prakash Ayurved Charak Sansthan

naimishraj@yahoo.com9560659728

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026